3. An Ebola virus (EBOV) vaccine, comprising: at least one ribonucleic acid (RNA) polynucleotide having an open reading frame encoding at least one EBOV antigenic polypeptide or an immunogenic fragment thereof. 4. The vaccine of claim 3, wherein the at least one antigenic polypeptide is sele...
Package Insert https://www.fda.gov/media/133748/download Cohen J. Worries about Ebola outbreak grow, despite use of vaccine. Science. 2018;362:1225. https://doi.org/10.1126/science.362.6420.1225. Article CAS PubMed Google Scholar Malvy D, McElroy AK, de Clerck H, et al. Ebola virus...